Catalyst Wire Dossier Catalyst Wire Dossier

Dengue Tetravalent Vaccine (TDV)

Dengue tetravalent vaccine · Takeda
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Dengue Tetravalent Vaccine (TDV), covering 2024-02-07 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years) [Phase 3]

See pricing